Compounds > pyrimidine
Page last updated: 2024-08-21

pyrimidine and Granulocytic Leukemia, Chronic

pyrimidine has been researched along with Granulocytic Leukemia, Chronic in 3 studies

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19901 (33.33)18.7374
1990's0 (0.00)18.2507
2000's1 (33.33)29.6817
2010's1 (33.33)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Ding, K; Lu, X; Luo, J; Pan, X; Ren, X; Wang, D; Yu, R; Zhang, Z; Zhuang, X1
Sausville, EA1
BONO, VH; FREI, E; WEISSMAN, SM1

Other Studies

3 other study(ies) available for pyrimidine and Granulocytic Leukemia, Chronic

ArticleYear
Hybrid pyrimidine alkynyls inhibit the clinically resistance related Bcr-Abl(T315I) mutant.
    Bioorganic & medicinal chemistry letters, 2015, Sep-01, Volume: 25, Issue:17

    Topics: Cell Proliferation; Fusion Proteins, bcr-abl; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Models, Molecular; Mutation; Pyrimidines

2015
Is another bcr-abl inhibitor needed for chronic myelogenous leukemia?
    Clinical cancer research : an official journal of the American Association for Cancer Research, 2003, Volume: 9, Issue:4

    Topics: Benzamides; Fusion Proteins, bcr-abl; Humans; Imatinib Mesylate; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Piperazines; Pyridines; Pyrimidines

2003
THE EFFECT OF 6-AZAURIDINE ADMINISTRATION ON DE NOVO PYRIMIDINE PRODUCTION IN CHRONIC MYELOGENOUS LEUKEMIA.
    The Journal of clinical investigation, 1964, Volume: 43

    Topics: Azauridine; Leukemia; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Leukemia, Myeloid; Metabolism; Nucleosides; Pharmacology; Pyrimidines

1964